XML 43 R32.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation (Tables)

9 Months Ended

Dec. 31, 2022

Share-based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Repurchase Agreements

The following table summarizes total shares repurchased during the three and nine months ended December 31, 2022 and 2021:


			November 2020 Program												August 2022 Program												Total
(In millions)			Shares						Amount						Shares						Amount						Shares						Amount
Three months ended December 31, 2022			—						$	5					2.6						$	320					2.6						$	325
Nine months ended December 31, 2022			5.1						$	650					2.6						$	320					7.7						$	970
Three months ended December 31, 2021			2.4						$	325					—						$	—					2.4						$	325
Nine months ended December 31, 2021			7.0						$	975					—						$	—					7.0						$	975

Disclosure Of Stock-Based Compensation Arrangements By Stock-Based Payment Award

The following table summarizes our stock option activity for the nine months ended December 31, 2022:


						Options (in thousands)						Weighted- Average Exercise Prices						Weighted- Average Remaining Contractual Term (in years)						Aggregate Intrinsic Value (in millions)
Outstanding as of March 31, 2022						286						$	39.28

Granted						2						125.55
Exercised						(164)						39.47
Forfeited, cancelled or expired						(1)						64.95
Outstanding as of December 31, 2022						123						$	40.69					2.21						$	10
Vested and expected to vest						123						$	40.69					2.21						$	10
Exercisable as of December 31, 2022						122						$	40.04					2.16						$	10

The following table summarizes our restricted stock units activity for the nine months ended December 31, 2022:


			Restricted Stock Units (in thousands)						Weighted- Average Grant Date Fair Values
Outstanding as of March 31, 2022			6,682						$	129.57

Granted			4,970						127.44
Vested			(3,332)						126.20
Forfeited or cancelled			(695)						131.78
Outstanding as of December 31, 2022			7,625						$	129.45

The following table summarizes our performance-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2022:


			Performance- Based Restricted Stock Units (in thousands)						Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2022			190						$	142.60
Granted			509						127.98
Vested			(73)						142.60
Forfeited or cancelled			(69)						136.28
Outstanding as of December 31, 2022			557						$	130.03

The following table summarizes our market-based restricted stock unit activity, presented with the maximum number of shares that could potentially vest, for the nine months ended December 31, 2022:


			Market-Based Restricted Stock Units (in thousands)						Weighted- Average Grant Date Fair Value
Outstanding as of March 31, 2022			1,321						$	134.69
Granted			178						176.70
Vested			(95)						114.97
Forfeited or cancelled			(582)						129.16
Outstanding as of December 31, 2022			822						$	149.98

The following table summarizes stock-based compensation expense resulting from stock options, restricted stock units, market-based restricted stock units, performance-based restricted stock units, and the ESPP purchase rights included in our Condensed Consolidated Statements of Operations (in millions):


			Three Months Ended December 31,												Nine Months Ended December 31,
			2022						2021						2022						2021
Cost of revenue			$	2					$	1					$	5					$	4
Research and development			95						86						271						272
Marketing and sales			15						14						44						41
General and administrative			29						28						86						86
Stock-based compensation expense			$	141					$	129					$	406					$	403